v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net loss $ (1,606) $ (1,592)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation expense 78 137
Change in fair value of warrants 0 (294)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 157 203
Other assets 0 (1)
Accounts payable 434 (531)
Accrued expense 62 (160)
Cash used in operating activities (875) (2,238)
Financing activities:    
Proceeds from the sale of common stock and common stock warrants in private placement, net of issuance costs 0 635
Cash provided by financing activities 0 635
Net decrease in cash and cash equivalents (875) (1,603)
Cash and cash equivalents at beginning of period 6,375 8,289
Cash and cash equivalents at end of period 5,500 6,686
Supplemental schedule of non-cash investing and financing activities:    
Accretion (amortization) of redeemable convertible preferred stock to redemption value 1,718 (1,508)
Reclassification of warrant liability to additional paid-in capital $ 0 $ 761